Skip to content

The optimal puncture time point of prolonged occlusion flow-mediated dilatation in radial artery catheterization

The optimal puncture time point of prolonged occlusion flow-mediated dilatation in radial artery catheterization

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200066214
Enrollment
Unknown
Registered
2022-11-28
Start date
2022-12-01
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

prolonged occlusion flow-mediated dilatation

Interventions

cardiovascular disease low-risk group:prolonged occlusion flow-mediated dilatation
cardiovascular disease lhigh-risk group:prolonged occlusion flow-mediated dilatation
pulse palpation group:radial artery catheterization
prolonged occlusion flow-mediated dilatation group:radial artery catheterization after PO-FMD

Sponsors

The First Hospital of Jilin University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Age >= 18 years old, ASA classification I~III, and all patients who have awakened from general anesthesia in the First Hospital of Jilin University. 2. Age >= 18 years old, ASA classification I~III, and patients undergoing invasive arterial blood pressure monitoring.

Exclusion criteria

Exclusion criteria: Patients who had a severe peripheral vascular disease or who had coagulation function abnormalities or who had instability hemodynamics were excluded from the study.

Design outcomes

Primary

MeasureTime frame
The time point at which the radial artery diameter is expanded to the maximum.;puncture attempts;

Secondary

MeasureTime frame
the time of radial artery dilatation induced after PO-FMD;the degree of radial artery dilatation induced after PO-FMD;radial artery puncture complications;

Countries

China

Contacts

Public ContactMa Haichun

The First Hospital of Jilin University

mahaichun2003@163.com13756915700

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 9, 2026